肝脏血流动力学变化对肝纤维化分期诊断价值

肝脏 ›› 2023, Vol. 28 ›› Issue (11): 1289-1292.

肝脏血流动力学变化对肝纤维化分期诊断价值

陈勇良, 李若旭, 闫伟静, 王永莎, 王晓静, 李秋雨, 李振燕

050021 河北石家庄市第五医院感染科(陈勇良,王晓静,李秋雨),影像科(李若旭,闫伟静,王永莎,李振燕)

收稿日期:2023-03-09 出版日期:2023-11-30 发布日期:2024-03-03
通讯作者: 李振燕,Email:swycsl@163.com
基金资助:
石家庄市科学技术研究与发展计划(201201243) ;河北省医学科学研究课题计划(20221689)

The diagnostic value of hepatic hemodynamic changes in staging liver fibrosis

CHEN Yong-liang¹, LI Ruo-xu², YAN Wei-jing², WANG Yong-sha², WANG Xiao-jing¹, LI Qiu-yu¹, LI Zhen-yan²

1. Department of Infectious Diseases, Shijiazhuang Fifth Hospital, Hebei 050021, China;
2. Department of Imaging, Shijiazhuang Fifth Hospital, Hebei 050021, China

Received:2023-03-09 Online:2023-11-30 Published:2024-03-03
Contact: LI Zhen-yan, Email:swycsl@163.com

摘要/Abstract

摘要： 目的探讨肝脏血流动力学软件在肝纤维化分期中的应用价值。方法选取2017年1月—2021年10月于石家庄市第五医院就诊行彩色多普勒检查肝脏检查并行肝组织穿刺活检的慢性乙型肝炎患者148例。应用彩色多普勒超声检测门静脉、肝左静脉、肝中静脉及肝右静脉频谱波形,M型超声测量心率。将频谱图像及心率上传至杭州精康科技有限责任公司生产的肝脏血流动力检测软件系统内,计算出肝纤维化值,与肝组织穿刺活检病理诊断对照。结果 148例患者肝组织活检病理诊断0期32例,1期39例,2期24例,3期12例,4期41例。根据肝血流动力学软件诊断值,将148例患者分为4组,其ROC 曲线下面积分别为AUC=0.91(95％可信区间0.867~0.959)、0.962(95％可信区间0.938~0.987)、0.975(95％可信区间0.956~0.994)、0.966(95％可信区间0.940~0.993)。根据约登指数最大原则,肝血流动力学软件诊断≥S1、S2、S3、S4期的截断值分别为1.27、3.78、3.98、5.85。肝脏血流动力学软件在评估有无严重纤维化、肝硬化时评估准确性较高,各期AUC均大于0.9,其中S3＞S4＞S2＞S1期。结论肝脏血流动力学软件作为一种新型的无创检测肝纤维化方法,与肝纤维化分期病理改变具有良好的相关性,可较准确地评估肝脏纤维化程度,可在临床推广使用。

关键词: 肝脏血流动力学, 彩色多普勒超声, 门静脉, 肝静脉, 肝纤维化分期

Abstract: Objective To explore the application value of “Liver Hemodynamics Software” in diagnosing liver fibrosis stages.Methods The spectrum waveforms of portal vein, left hepatic vein, middle hepatic vein and right hepatic vein were detected by color Doppler ultrasound, and the heart rates were measured by M-mode ultrasound. The spectrum images and heart rates were uploaded to the “Liver Hemodynamics Software” system produced by Hangzhou Jingkang Technology. The liver fibrosis values were then calculated, and further compared with the pathological diagnosis of Percutaneous Liver Biopsies.Results Among 148 patients, 32 cases were diagnosed as stage 0, 39 cases as stage 1, 24 cases as stage 2, 12 cases as stage 3 and 41 cases as stage 4. According to the diagnostic values of Liver Hemodynamics Software, 148 patients were divided into four groups, and the area under the receiver operating characteristic curve (AUC) of each group was AUC=0.91 (95% confidence interval 0.867~0.959), 0.962 (95% confidence interval 0.938~0.987), 0.975 (95% confidence interval 0.956~0.994), and 0.966 (95% confidence interval 0.940~0.993), respectively. According to the principle of maximum Jordan index, the cutoff values of staging liver fibrosis for ≥ S1, S2, S3 and S4 by liver hemodynamics software were 1.27, 3.78, 3.98 and 5.85, respectively. The Liver Hemodynamics Software showed a high accuracy in assessing whether there had severe fibrosis and cirrhosis. The AUC of each phase was greater than 0.9, of which S3>S4>S2>S1.Conclusion As a new non-invasive method for detecting liver fibrosis, the liver fibrosis values obtained by Liver Hemodynamics Software has a good correlation with the pathological stagings of liver fibrosis, thus may accurately evaluate the degrees of liver fibrosis, and can be widely used in clinical practice.

Key words: Hepatic hemodynamics, Color Doppler ultrasound, Portal vein, Hepatic vein, liver fibrosis Stages

陈勇良, 李若旭, 闫伟静, 王永莎, 王晓静, 李秋雨, 李振燕. 肝脏血流动力学变化对肝纤维化分期诊断价值[J]. 肝脏, 2023, 28(11): 1289-1292.

CHEN Yong-liang, LI Ruo-xu, YAN Wei-jing, WANG Yong-sha, WANG Xiao-jing, LI Qiu-yu, LI Zhen-yan. The diagnostic value of hepatic hemodynamic changes in staging liver fibrosis[J]. Chinese Hepatolgy, 2023, 28(11): 1289-1292.

参考文献

[1] Ghany MG, Strader DB, et al. Diagnosis, management, and treatment of hepatitis C. Hepatology,2004,39(4):1147-1171.
[2] 中华医学会肝病学分会. 中华医学会消化病学分会,中华医学会感染病学分会. 肝纤维化诊断及治疗共识(2019年). 临床肝胆病杂志,2019,35(10):2163-2172.
[3] Lin YS. Ultrasound evaluation of liver fibrosis. J Med Ultrasound,2017,25(3): 127-129.
[4] European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol,2015,63(1):237-264.
[5] Andersen ES, Christensen PB, Weis N. Transient elastography for liver fibrosis diagnosis. Eur J Intern Med,2009,20(4):339-342.
[6] Kwon YD, Ko Ko, Lim JW, et al. Usefulness of transient elastography for non-invasive diagnosis of liver fibrosis in pediatric nonalcoholic steatohepatitis. J Korean Med Sci,2019,34(23):e165.
[7] 陈曼, 詹维伟, 周建桥, 等. 肝静脉频谱波形分析对肝纤维化的临床价值研究. 中国超声医学杂志,2008,24(1):41-43.
[8] 孟繁坤, 郑颖, 葛辉玉, 等. 慢性肝炎肝静脉彩色多普勒超声频谱改变与肝纤维化分期相关性的研究. 中华超声影像学杂志,2006,15(4):298-299.
[9] 王诚, 陈厚斌, 马龙, 等. 肝动脉血流阻力指数对非酒精性脂肪性肝病患者进展期肝纤维化的评估价值. 临床肝胆病杂志,2018,34(12):97-100.
[10] Topal NB, Orcan S, Sigiri D, et al. Effects of fat accumulation in the liver on hemodynamic variables assessed by Doppler ultrasonography. J Clin Ultrasound,2015,43(1):26-33.
[11] 孟海生, 胡冬梅, 李莎莎, 等. 超声量化指标与肝静脉波形分型在评价乙肝患者肝纤维化程度中的临床意义. 中国超声医学杂志,2021,37(1):59-62.
[12] 张洪, 张佳, 周家龙, 等. 肝静脉直径、改良肝尾叶/右叶比值对肝纤维化和肝硬化病理学分期的诊断价值. 中国医学影像学杂志,2020,28(7):529-534.
[13] Bosch J, Abraldes J G, Berzigotti A, et al. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol,2009,6(10):573-582.
[14] Qi X, Berzigotti A, Cardenas A, et al. Emerging noninvasive approaches for diagnosis and monitoring of portal hypertension. Lancet Gastroenterol Hepatol,2018,3(10):708-719.
[15] 明芳, 秦刚, 李民, 等. FibroTouch在慢性肝病中临床的应用及与多参数模型的比较. 重庆医学,2017,46(36):5101-5103.